Guidelines for palliative surgery of cholangiocarcinoma.
The aims of the guidelines are to help assess the evidence for palliation surgery in patients with cholangiocarcinoma (CCA). The guidelines are classified in accordance with the location of the primary lesion, i.e. intrahepatic, hilar, and distal. They are based on comprehensive literature surveys, including results from randomized controlled trials, systematic reviews and meta-analysis, and cohort, prospective, and retrospective studies. Intrahepatic CCA, i.e. resection of lymph-node-positive tumors and R1/R2 resections have not been shown to provide survival benefit: Evidence levels: 2b, 4; Recommendation grade C. Hilar CCA: R1 resection is justified as a very efficient palliation. Non-surgical biliary stenting is the first choice of palliative biliary drainage. Distal CCA: Resection of lymph-node-positive tumours and R1/R2 resections should be performed. Non-surgical stenting is regarded as the first choice of palliation for patients with short life expectancy. For patients with longer projected survival, surgical bypass should be considered. Palliative resections have a relevant beneficial impact on the outcome of patients with distal and hilar CCA. Non-surgical stenting is the first choice of palliative biliary drainage for patients with hilar CCA and for those with distal CCA and short life expectancy. For patients with distal CCA and longer projected survival, surgical bypass should be considered.
Witzigmann
H
H
Department of General and Visceral Surgery, Hospital Dresden-Friedrichstadt, Dresden, Germany. witzigmann-he@khdf.de
Lang
H
H
Lauer
H
H
Ann Surg. 2003 Jan;237(1):66-73
12496532
Cancer. 1997 Jan 1;79(1):26-34
8988723
Ann Surg. 2003 Feb;237(2):201-7
12560778
Surgery. 2000 May;127(5):498-505
10819057
Gut. 1989 Aug;30(8):1132-5
2475392
Ann Surg. 2005 Jan;241(1):77-84
15621994
Hepatobiliary Pancreat Dis Int. 2006 May;5(2):278-82
16698591
Br J Surg. 2000 Sep;87(9):1182-7
10971425
Ann Surg. 2005 May;241(5):703-12; discussion 712-4
15849506
Br J Surg. 1998 Aug;85(8):1068-70
9717998
Ann Surg. 2006 Aug;244(2):230-9
16858185
Br J Surg. 2002 Dec;89(12):1525-31
12445060
Ann Surg. 2007 May;245(5):755-62
17457168
Br J Surg. 1987 Oct;74(10):952-4
2444310
Ann Surg. 2003 Jul;238(1):84-92
12832969
Ann Surg. 2001 Mar;233(3):385-92
11224627
Lancet. 1994 Dec 17;344(8938):1655-60
7996958
J Am Coll Surg. 2007 Feb;204(2):250-60
17254929
Ann Surg. 1999 Nov;230(5):663-71
10561090
Ann Surg. 2005 May;241(5):693-9; discussion 699-702
15849505
Chirurg. 2006 Jan;77(1):53-60
16170505
Hepatogastroenterology. 2007 Mar;54(74):346-9
17523271
Ann Surg. 1996 Jun;223(6):718-25; discussion 725-8
8645045
Ann Surg. 2005 Jan;241(1):134-43
15622001
Ann Surg. 2003 Jul;238(1):73-83
12832968
Br J Surg. 1993 Nov;80(11):1434-9
7504567
Ann Surg. 1996 Nov;224(5):628-38
8916878
Am J Surg. 2002 Jun;183(6):679-85
12095601
Am J Surg. 1992 Feb;163(2):208-12
1371206
J Am Coll Surg. 2001 Oct;193(4):384-91
11584966
Gut. 1991 Jun;32(6):685-9
1711994
Mayo Clin Proc. 1995 May;70(5):425-9
7537346
Arch Surg. 1998 Mar;133(3):293-6
9517743
Surgery. 1994 May;115(5):597-603
7513906
Hepatobiliary Pancreat Dis Int. 2003 Feb;2(1):110-3
14607660
Am J Surg. 2008 Feb;195(2):221-8
18154768
Eur J Surg Oncol. 2007 Aug;33(6):757-62
17215099
J Surg Oncol. 2007 Mar 1;95(3):207-12
17278119
Cancer Treat Rev. 2007 Apr;33(2):213-21
17157990
Hepatogastroenterology. 2001 Jul-Aug;48(40):1129-33
11490816
Ann Surg. 1994 Jan;219(1):18-24
7507656
Gastrointest Endosc. 1988 Mar-Apr;34(2):95-101
2835282
Br J Surg. 1988 Dec;75(12):1166-8
2466520
Ann Surg. 2001 Oct;234(4):507-17; discussion 517-9
11573044
J Am Coll Surg. 1998 Oct;187(4):365-72
9783782
Am J Surg. 1998 Jun;175(6):453-60
9645771